arrow
F

Fabio Arena

University of Perugia
H指数:29
被引数:4,636

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Whole-Genome Sequencing Identified Co-Circulating VIM-Producing Serratia bockelmannii and Serratia sarumanii in a Neonatal Intensive Care Unit Cluster Investigation

全基因组测序鉴定出新生儿重症监护室聚集事件中共同流行的产VIM酶的沙雷氏菌博克曼ii亚种和沙雷氏菌萨鲁马尼ii亚种

2026-10-010
OA
Building-level wastewater surveillance of antimicrobial resistance in the general, student and hospital-associated populations

对普通人群、学生和医院相关人群进行抗生素耐药性的楼宇级废水监测

2026-08-200
OAAI
Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor/tezacaftor/ivacaftor is clinical strain-dependent in patient-derived nasal cells (vol 11, 009702024, 2025)

铜绿假单胞菌(Pseudomonas aeruginosa)对F508del-CFTR的抑制作用,在由elexacaftor/tezacaftor/ivacaftor恢复后,在患者来源的鼻细胞中表现出临床菌株依赖性(vol 11, 009702024, 2025)

2025-12-154
PRE
Evaluation of a digital remote extraction analysis and monitoring tool for key performance indicators (KPIs) in the blood culture process

对血液培养过程中关键绩效指标(KPIs)的数字远程提取分析及监测工具的评估

2025-08-180
OAAI
Resistance to ceftazidime-avibactam and other new β-lactams in Pseudomonas aeruginosa clinical isolates: a multi-center surveillance study

铜绿假单胞菌临床分离株对头孢他啶-阿维巴坦和其他新型 β-内酰胺类抗生素的耐药性: 一项多中心监测研究

2024-08-065
OAAI
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

头孢地洛尔对欧洲肠杆菌的体外活性,包括对美罗培南和最近的 β-内酰胺/β-内酰胺酶抑制剂组合耐药的分离株

2024-08-067
OAAI